Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON) [Phase 1]
Phase 1 trial update for CAVATAK (CVA21) in non-muscle invasive bladder cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update investigating bladder preservation using radiotherapy and immunotherapy in patients with BCG-unresponsive non-muscle-in…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer [Phase 4]
A Phase 4 clinical trial evaluating the value of immediate post-operative intravesical epirubicin in intermediate- and high-risk non-muscle …
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) [Phase 3]
Phase 3 trial of apaziquone versus placebo in non-muscle invasive bladder cancer was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection [Phase 1]
Phase 1 trial evaluating the pharmacokinetics and elimination of Ethacrynic acid in patients with non-muscle-invasive bladder cancer undergo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) [Phase 3]
Phase 3 trial SPI-612 evaluated a single-dose intravesical apaziquone after TURBT for non-muscle-invasive bladder cancer; results have been …
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients [Phase 2]
Phase 2 safety study evaluating escalating doses of TC-3 Gel in combination with intravesical mitomycin C for non-muscle invasive bladder ca…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC [NA]
A completed study evaluating pre-TURBT instillation of TC-3 Gel intravesically in non-muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? [Phase 4]
A Phase 4 trial assessing predictive models for recurrence and progression in non-muscle invasive bladder cancer, comparing EORTC and CUETO …
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating a single immediate instillation of EO9 after TURBT in non-muscle-invasive bladder cancer has been termina…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial evaluating multi-instillations of apaziquone for non-muscle invasive bladder cancer was terminated, and results on efficacy an…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients [NA]
A pilot study evaluating the clinical response to intravesical Mitomycin-C in a hydrogel formulation (TC-3) for non-muscle invasive bladder …
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluated the Mycobacterial Cell Wall-DNA Complex in patients with non-muscle invasive bladder cancer that…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
A completed study investigating whether genetic factors influence recurrence and progression in non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients [Phase 3]
A Phase 3 trial comparing intravesical mitomycin C with Bacillus Calmette-Guerin for non-muscle-invasive bladder cancer was terminated, with…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the maximum tolerable intravesical concentration of abnobaVISCUM Fraxini in patients with superficial bladder c…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer [Phase 2]
Phase 2 study evaluating TMX-101 for carcinoma in situ of the bladder and non-muscle-invasive bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating celecoxib for non-muscle invasive bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder [Phase 3]
A Phase 3 trial evaluating maintenance valrubicin versus no maintenance after valrubicin induction in bladder carcinoma in situ; study termi…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial comparing EN3348 (mycobacterial cell wall-DNA complex) to mitomycin C for intravesical treatment of BCG-recurrent/refractory n…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
Clinical trial results update on the effectiveness of Hexaminolevulinate (Hexvix) for diagnosing and treating non-muscle invasive bladder ca…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer [Phase 3]
Phase 3 randomized trial comparing Hexvix fluorescence cystoscopy to standard cystoscopy in non-muscle invasive bladder cancer. Results were…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer [Phase 2]
Phase 2b trial update for intravesical DTA-H19/PEI in intermediate-risk superficial bladder cancer has completed with results posted in 2013…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Intravesical Adjuvant Electromotive Mitomycin-C [Phase 2, Phase 3]
Clinical trial update announcing completion of Phase 2/3 evaluation of intravesical adjuvant electromotive delivery of mitomycin-C for bladd…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer [Phase 1]
Phase 1 clinical trial update for Cis-urocanic acid (Cis-UCA) in patients with primary or recurrent non-muscle invasive bladder cancer; stud…